Liver/kidney Microsomal Antibody Type 1 Targets CYP2D6 on Hepatocyte Plasma Membrane

Overview

Journal Gut

Specialty Gastroenterology

Date 2000 Mar 15

PMID 10716687

Citations 30

Authors

L Muratori

M Parola

A Ripalti

G ROBINO

P Muratori

G Bellomo

R Carini

M Lenzi

M P Landini

E Albano

F B Bianchi

Affiliations

Soon will be listed here.

Abstract

Background: Liver/kidney microsomal antibody type 1 (LKM1) is the marker of type 2 autoimmune hepatitis (AIH) and is detected in up to 6% of patients with hepatitis C virus (HCV) infection. It recognises linear and conformational epitopes of cytochrome P450IID6 (CYP2D6) and may have liver damaging activity, provided that CYP2D6 is accessible to effector mechanisms of autoimmune attack.

Methods: The presence of LKM1 in the plasma membrane was investigated by indirect immunofluorescence and confocal laser microscopy of isolated rat hepatocytes probed with 10 LKM1 positive sera (five from patients with AIH and five from patients with chronic HCV infection) and a rabbit polyclonal anti-CYP2D6 serum.

Results: Serum from both types of patient stained the plasma membrane of non-permeabilised cells, where the fluorescent signal could be visualised as discrete clumps. Conversely, permeabilised hepatocytes showed diffuse submembranous/cytoplasmic staining. Adsorption with recombinant CYP2D6 substantially reduced plasma membrane staining and LKM1 immunoblot reactivity. Plasma membrane staining of LKM1 colocalised with that of anti-CYP2D6. Immunoprecipitation experiments showed that a single 50 kDa protein recognised by anti-CYP2D6 can be isolated from the plasma membrane of intact hepatocytes.

Conclusions: AIH and HCV related LKM1 recognise CYP2D6 exposed on the plasma membrane of isolated hepatocytes. This observation supports the notion that anti-CYP2D6 autoreactivity may be involved in the pathogenesis of liver damage.

Citing Articles

B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis.

Longhi M, Zhang L, Mieli-Vergani G, Vergani D Autoimmun Rev. 2024; 23(7-8):103591.

PMID: 39117005 PMC: 11409799. DOI: 10.1016/j.autrev.2024.103591.

Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells.

Qiu Z, Huang L, Wang X, Wang Z, Li X, Feng B J Clin Transl Hepatol. 2024; 12(7):659-666.

PMID: 38993508 PMC: 11233981. DOI: 10.14218/JCTH.2023.00531.

Neonatal Lupus presenting with neonatal hemochromatosis-like liver disease that responded to steroids: a case report.

Khayat A, Alkhaldi A BMC Pediatr. 2022; 22(1):630.

PMID: 36329404 PMC: 9632081. DOI: 10.1186/s12887-022-03713-4.

B cells in autoimmune hepatitis: bystanders or central players?.

Schultheiss C, Steinmann S, Lohse A, Binder M Semin Immunopathol. 2022; 44(4):411-427.

PMID: 35488094 PMC: 9256567. DOI: 10.1007/s00281-022-00937-5.

Chinese medicine in the treatment of autoimmune hepatitis: Progress and future opportunities.

Liu J, Ma Z, Li H, Li X Animal Model Exp Med. 2022; 5(2):95-107.

PMID: 35263512 PMC: 9043711. DOI: 10.1002/ame2.12201.

References

Rizzetto M, Swana G, Doniach D . Microsomal antibodies in active chronic hepatitis and other disorders. Clin Exp Immunol. 1973; 15(3):331-44. PMC: 1553909. View

Riley R, Smith G, Wolf C, Cook V, Leeder J . Human anti-endoplasmic reticulum autoantibodies produced in aromatic anticonvulsant hypersensitivity reactions recognise rodent CYP3A proteins and a similarly regulated human P450 enzyme(s). Biochem Biophys Res Commun. 1993; 191(1):32-40. DOI: 10.1006/bbrc.1993.1180. View

Sirica A, Pitot H . Drug metabolism and effects of carcinogens in cultured hepatic cells. Pharmacol Rev. 1979; 31(3):205-28. View

Maslansky C, Williams G . Primary cultures and the levels of cytochrome P450 in hepatocytes from mouse, rat, hamster, and rabbit liver. In Vitro. 1982; 18(8):683-93. DOI: 10.1007/BF02796423. View

Lenzi M, Bianchi F, Cassani F, Pisi E . Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM). Clin Exp Immunol. 1984; 55(1):36-40. PMC: 1535786. View

HOMBERG J, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil S . Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology. 1987; 7(6):1333-9. DOI: 10.1002/hep.1840070626. View

Lenzi M, Fusconi M, Selleri L, Caselli A, Cassani F, Bianchi F . Counterimmunoelectrophoresis (CIE) for the detection of anti-liver-kidney microsome (LKM) antibodies in the sera of patients with chronic liver disease. J Immunol Methods. 1988; 111(2):253-9. DOI: 10.1016/0022-1759(88)90134-2. View

Zanger U, Hauri H, Loeper J, HOMBERG J, Meyer U . Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci U S A. 1988; 85(21):8256-60. PMC: 282408. DOI: 10.1073/pnas.85.21.8256. View

Martini E, Abuaf N, Cavalli F, Durand V, Johanet C, HOMBERG J . Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2. Hepatology. 1988; 8(6):1662-6. DOI: 10.1002/hep.1840080632. View

10.

Manns M, Johnson E, Griffin K, Tan E, Sullivan K . Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest. 1989; 83(3):1066-72. PMC: 303785. DOI: 10.1172/JCI113949. View

11.

Myrset A, Halvorsen B, Ording E, Helgeland L . The time courses of intracellular transport of some secretory proteins of rat liver are not affected by an induced acute phase response. Eur J Cell Biol. 1993; 60(1):108-14. View

12.

Trautwein C, Gerken G, Lohr H, Meyer zum Buschenfelde K, Manns M . Lack of surface expression for the B-cell autoepitope of cytochrome P450 IID6 evidenced by flow cytometry. Z Gastroenterol. 1993; 31(4):225-30. View

13.

Yamamoto A, Cresteil D, HOMBERG J, Alvarez F . Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera. Gastroenterology. 1993; 104(6):1762-7. DOI: 10.1016/0016-5085(93)90657-x. View

14.

Vergani D, Mieli-Vergani G . Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6. Clin Exp Immunol. 1993; 92(3):367-8. PMC: 1554764. DOI: 10.1111/j.1365-2249.1993.tb03406.x. View

15.

Yamamoto A, Mura C, Krishnamoorthy R, Alvarez F . Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes. Clin Exp Immunol. 1993; 92(3):381-90. PMC: 1554760. DOI: 10.1111/j.1365-2249.1993.tb03409.x. View

16.

Johnson P, McFarlane I . Meeting report: International Autoimmune Hepatitis Group. Hepatology. 1993; 18(4):998-1005. DOI: 10.1002/hep.1840180435. View

17.

Muratori L, Zauli D, Giostra F, Ballardini G, Lenzi M, Cassani F . LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment. J Hepatol. 1993; 18(2):259-60. DOI: 10.1016/s0168-8278(05)80258-2. View

18.

Winqvist O, Gustafsson J, Rorsman F, Karlsson F, Kampe O . Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest. 1993; 92(5):2377-85. PMC: 288420. DOI: 10.1172/JCI116843. View

19.

Mackie F, Peakman M, Yun M, Sallie R, Smith H, Davies E . Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus. Gastroenterology. 1994; 106(6):1672-5. DOI: 10.1016/0016-5085(94)90426-x. View

20.

Ma Y, Peakman M, Wen L, Lenzi M, Gaken J, Farzaneh F . Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection. Clin Exp Immunol. 1994; 97(1):94-9. PMC: 1534799. DOI: 10.1111/j.1365-2249.1994.tb06585.x. View